Papagikos Michael A, Rossi Peter J, Lee W Robert
Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA.
J Am Coll Radiol. 2005 Jan;2(1):72-5. doi: 10.1016/j.jacr.2004.06.025.
One of the explicit goals of the American Society of Therapeutic Radiology and Oncology (ASTRO) is to promote research and disseminate research results. In the past few years, ASTRO has required that manuscripts be submitted for publication for all papers accepted for oral presentation at its annual meeting. The purpose of this study was to determine the publication rate of abstracts accepted for oral presentation at ASTRO's 1999, 2000, and 2001 annual meetings.
The authors reviewed the proceedings of ASTRO's annual meetings in 1999, 2000, and 2001 to identify all abstracts accepted for oral presentation. The following information was collected: year of presentation, study design (phase I or II, phase III, or retrospective), country of origin (domestic or foreign), abstract category (clinical or nonclinical), disease site (if applicable), publication (yes or no), publication date, and publishing journal. A computer-based search using Medline was used to determine whether the full publication of each abstract had occurred. The computer search included publication up to November 1, 2003.
The publication rate was 56% (452 of 802). There was no difference in publication rate according to country of origin (domestic 56%, foreign 57%; p = NS), abstract category (clinical 59%, nonclinical 48%; p = NS), or study design. Half of the published abstracts were published within 1 year of the meeting, and 90% were published within 2 years. The 452 publications were distributed among 54 different journals. The majority of papers were published in the International Journal of Radiation Oncology, Biology and Physics (62%), followed by the Journal of Clinical Oncology (8%) and Radiotherapy and Oncology (3%).
Slightly more than one-half of the abstracts accepted for oral presentation at the annual ASTRO meeting are published within 2 years. This rate is similar to those of other specialties and suggests that ASTRO is succeeding in its mission to promote and disseminate research.
美国放射肿瘤学会(ASTRO)的明确目标之一是促进研究并传播研究成果。在过去几年中,ASTRO要求将在其年会上接受口头报告的所有论文提交发表。本研究的目的是确定在ASTRO 1999年、2000年和2001年年会上接受口头报告的摘要的发表率。
作者回顾了ASTRO 1999年、2000年和2001年年会的会议记录,以确定所有接受口头报告的摘要。收集了以下信息:报告年份、研究设计(I期或II期、III期或回顾性)、原产国(国内或国外)、摘要类别(临床或非临床)、疾病部位(如适用)、发表情况(是或否)、发表日期和发表期刊。使用Medline进行基于计算机的搜索,以确定每个摘要是否已全文发表。计算机搜索涵盖截至2003年11月1日的发表情况。
发表率为56%(802篇中的452篇)。根据原产国(国内56%,国外57%;p=无显著性差异)、摘要类别(临床59%,非临床48%;p=无显著性差异)或研究设计,发表率没有差异。一半的已发表摘要在会议后1年内发表,90%在2年内发表。452篇出版物分布在54种不同的期刊上。大多数论文发表在《国际放射肿瘤学、生物学与物理学杂志》(62%),其次是《临床肿瘤学杂志》(8%)和《放射治疗与肿瘤学》(3%)。
在ASTRO年会上接受口头报告的摘要中,略多于一半在2年内发表。这个比率与其他专业相似,表明ASTRO在促进和传播研究的使命中取得了成功。